New Zealand markets closed

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5400+0.0100 (+0.65%)
At close: 04:00PM EDT
1.5108 -0.03 (-1.90%)
After hours: 04:33PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.55M
Enterprise value 22.31M
Trailing P/E 0.36
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.90
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.15

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3-43.17%
S&P500 52-week change 332.65%
52-week high 37.3300
52-week low 31.4900
50-day moving average 31.8342
200-day moving average 33.3790

Share statistics

Avg vol (3-month) 380.18k
Avg vol (10-day) 364.26k
Shares outstanding 510.75M
Implied shares outstanding 611.13M
Float 87.94M
% held by insiders 126.51%
% held by institutions 14.76%
Shares short (13 Sept 2024) 4426.49k
Short ratio (13 Sept 2024) 43.79
Short % of float (13 Sept 2024) 44.80%
Short % of shares outstanding (13 Sept 2024) 43.97%
Shares short (prior month 15 Aug 2024) 4474.64k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 302 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-115.97%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -23.26M
Net income avi to common (ttm)-24.83M
Diluted EPS (ttm)-2.6800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.9M
Total cash per share (mrq)0.17
Total debt (mrq)7.65M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.21
Book value per share (mrq)-1.72

Cash flow statement

Operating cash flow (ttm)-13.99M
Levered free cash flow (ttm)-7.35M